Search research articles
Contact Us
Filters
Showing results (231-240 of 283) with videos related to
Page
of 29
Sort By:
Clinical Chemistry and Laboratory Medicine
|
November 13, 2021
Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid
Johan Gobom, Lucilla Parnetti, Pedro Rosa-Neto, et al.
Neurobiology of Aging
|
February 8, 2020
CSF cutoffs for MCI due to AD depend on APOEε4 carrier status
Moira Marizzoni, Clarissa Ferrari, Claudio Babiloni, et al.
Brain : a Journal of Neurology
|
October 6, 2025
Reference proteins to improve Core 1 and Core 2 Alzheimer's disease CSF and plasma biomarkers
Linda Karlsson, Shorena Janelidze, Nicolas R Barthélemy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 11, 2019
Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study
Alberto Lleó, Daniel Alcolea, Pablo Martínez-Lage, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Biomarkers
Linda Karlsson, Shorena Janelidze, Nicolas R Barthélemy, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
October 16, 2025
Italian intersocietal recommendations for restructuring the diagnostic-therapeutic pathway for the implementation and appropriate use of anti-amyloid monoclonal antibodies in Alzheimer's disease
Alberto Benussi, Federica Agosta, Alba Rosa Alfano, et al.
Plos Medicine
|
August 21, 2020
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study
Hana Saddiki, Aurore Fayosse, Emmanuel Cognat, et al.
International Journal of Molecular Sciences
|
January 11, 2025
Resting-State EEG Alpha Rhythms Are Related to CSF Tau Biomarkers in Prodromal Alzheimer's Disease
Claudio Del Percio, Roberta Lizio, Susanna Lopez, et al.
Frontiers in Neurology
|
November 4, 2015
The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases
Babette L R Reijs, Charlotte E Teunissen, Nikolai Goncharenko, et al.
Journal of Alzheimer'S Disease : JAD
|
November 30, 2020
White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers
Linda J C van Waalwijk van Doorn, Mohsen Ghafoorian, Esther M C van Leijsen, et al.
Page
of 29
Search research articles
Search
Showing results (231-240 of 283) with videos related to
Sort By:
Page
of 29
Clinical Chemistry and Laboratory Medicine
|
November 13, 2021
Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid
Johan Gobom, Lucilla Parnetti, Pedro Rosa-Neto, et al.
Neurobiology of Aging
|
February 8, 2020
CSF cutoffs for MCI due to AD depend on APOEε4 carrier status
Moira Marizzoni, Clarissa Ferrari, Claudio Babiloni, et al.
Brain : a Journal of Neurology
|
October 6, 2025
Reference proteins to improve Core 1 and Core 2 Alzheimer's disease CSF and plasma biomarkers
Linda Karlsson, Shorena Janelidze, Nicolas R Barthélemy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 11, 2019
Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study
Alberto Lleó, Daniel Alcolea, Pablo Martínez-Lage, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Biomarkers
Linda Karlsson, Shorena Janelidze, Nicolas R Barthélemy, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
October 16, 2025
Italian intersocietal recommendations for restructuring the diagnostic-therapeutic pathway for the implementation and appropriate use of anti-amyloid monoclonal antibodies in Alzheimer's disease
Alberto Benussi, Federica Agosta, Alba Rosa Alfano, et al.
Plos Medicine
|
August 21, 2020
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study
Hana Saddiki, Aurore Fayosse, Emmanuel Cognat, et al.
International Journal of Molecular Sciences
|
January 11, 2025
Resting-State EEG Alpha Rhythms Are Related to CSF Tau Biomarkers in Prodromal Alzheimer's Disease
Claudio Del Percio, Roberta Lizio, Susanna Lopez, et al.
Frontiers in Neurology
|
November 4, 2015
The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases
Babette L R Reijs, Charlotte E Teunissen, Nikolai Goncharenko, et al.
Journal of Alzheimer'S Disease : JAD
|
November 30, 2020
White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers
Linda J C van Waalwijk van Doorn, Mohsen Ghafoorian, Esther M C van Leijsen, et al.
Page
of 29